aTyr Pharma, Inc. Profile Avatar - Palmy Investing

aTyr Pharma, Inc.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is…

Biotechnology
US, San Diego [HQ]
Growth Rates · Payout · Yield

Dividends Over Time

  • Records
  • Forecasts [Soon]
Growth Rates
% YoY
% 3Yr
% 5Yr
% 10Yr
Key Metrics
- -% TTM Yield
- - Average Days Gap
Series
% - - Yield
0.00% Payout Ratio
Cash Amount Pay Date
Cash Amount Pay Date
End of LIFE's Analysis
CIK: 1339970 CUSIP: 002120202 ISIN: US0021202025 LEI: - UEI: -
Secondary Listings
LIFE has no secondary listings inside our databases.